Advertisement

Zusammenfassung

Bei ausgewachsenen jungen Männern wiegt die Prostata ca. 30 g und weist einen sagittalen Durchmesser bis 2,5 cm auf. Nach abgeschlossener spezifischer Differenzierung unter Androgeneinfluß finden sich 30–50 Drüsenläppchen mit etwa 15–30 Ausführungsgängen. Diese münden in die Furchen seitlich des Colliculus seminalis ein. Die überwiegende Organmasse wird durch die Außendrüse gebildet. Diese umschließt die sogenannte Innendrüse, die durch eine fibromuskuläre Zone abgegrenzt ist. Das Gesamtorgan ist von einer kapsei- oder bandartigen Muskel- und Bindege-websschicht umgeben mit Gefäßen und Nerveneinschlüssen, die als sog. Prostatakapsel in der TNM-Klassifikation geführt wird (Ayala et al. 1989).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abrahamsson PA ,Wadström LB ,Alumets J ,Falkmer St ,Grimelius L (1987) Peptidehormone and serotonin-immuno reactive tumour cells in carcinomata of the prostate. Pathol Res Pract 182: 298–307PubMedGoogle Scholar
  2. Ackerman R ,Altwein JE ,Faul P (Hrsg) (1991) Aktuelle Therapie des Prostatakarzinoms. Springer ,Berlin Heidelberg New York TokyoGoogle Scholar
  3. Al-Abadi H ,Nagel R (1988) Prognostische Bedeutung von Ploidie und proliferativer Aktivität beim lokal fortgeschrittenen Prostatakarzinom. Aktuel Urol 19:182–186CrossRefGoogle Scholar
  4. Al-Abadi H ,Nagel R (1990) Nuclear DNA analysis: The relevance of ploidy ,DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years. Urol Int 45: 350–355PubMedCrossRefGoogle Scholar
  5. Allsbrook WC ,Simms WW (1992) Histochemistry of the prostate. Hum Pathol 23: 297–305PubMedCrossRefGoogle Scholar
  6. Altwein JE ,Faul P (1990) Probleme und Prinzipien der Hormontherapie des fortgeschrittenen Prostatakarzinoms. Klin Wochenschr 68: 347–358PubMedCrossRefGoogle Scholar
  7. Anichkov N (1991) Neuroendocrine cells (NEC) in normal and neoplastic epithelial structures of urethra. Pathol Res Pract 187: 650Google Scholar
  8. Aumüller G (1989) Morphologic and regulatory aspects of prostatic function. Anat Embryol 179: 519–531PubMedCrossRefGoogle Scholar
  9. Aumüller G ,Goebel HW ,Bacher M ,Eicheler W ,Rausch U (1993) Aktuelle morphologische und funktionelle Aspekte der Prostata. Verh Ges Pathol 77: 1–18Google Scholar
  10. Ayala AG ,Ro JY ,Babaian R ,Troncoso P. Grignon DJ (1989) The prostatic capsule: Does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13: 21–27PubMedCrossRefGoogle Scholar
  11. Babaian RJ ,Troncoso P Ayala A (1991) Transurethral-resection zone prostate cancer detected at cystoprostatectomy. A detailed histologic analysis and clinical implications. Cancer 67: 1418–1422PubMedCrossRefGoogle Scholar
  12. Badalament RA ,O’Toole RV ,Young DC ,Drago JR (1991) DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer. Cancer 67: 3014–3023PubMedCrossRefGoogle Scholar
  13. Bibbo M ,Kim DH ,Galera-Davidson H ,Di Loreto C ,Dytch HE (1990a) Architectural morphometric and photometric features and their relationship to the main subjective diagnostic clues in the grading of prostatic cancer. Anal Quant Cytol Histol 12: 85–90PubMedGoogle Scholar
  14. Bibbo M ,Kim DH ,Pfeifer T ,Dytch HE ,Galera-Davidson H ,Bartels PH (1991b) Histometric features for the grading of prostatic carcinoma. Anal Quant Cytol Histol 13: 61–68PubMedGoogle Scholar
  15. Bibbo M ,Kim DH. Di Loreto C et al. (1990c) Tissue architectural features for the grading of prostatic carcinoma. Anal Quant Cytol Histol 12: 229–236PubMedGoogle Scholar
  16. Böcking A (1990) DNA-Zytometrie und Automation in der klinischen Diagnostik. Beitr Onkol 38: 298–347Google Scholar
  17. Bologna M. Festuccia C ,Muzi P ,Biordi L ,Ciomei M (1989) Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63: 1714–1720PubMedCrossRefGoogle Scholar
  18. Bonkhoff H, Wernert N, Remberger K, Dhom G (1989) Topographische Lagebeziehung zwischen endokrin differenzierten Zellen und der Proliferationsfraktion in Prostatakarzinomen. Verh Dtsch Ges Pathol 73: 638Google Scholar
  19. Bonkhoff H, Wernert N, Dhom G, Remberger K (1991) Basement membranes in fetal, adult normal ,hyperplastic and neoplastic human prostate. Virchows Archiv [A] 418: 375–381CrossRefGoogle Scholar
  20. Bonkhoff H, Remberger K (1993) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch [A] 422: 35–38CrossRefGoogle Scholar
  21. Bonkhoff H, Wernert N, Dhom G, Remberger K (1992) Distribution of basement membranes in primary and metastatic carcinomas of the prostate. Hum Pathol 23: 934– 939PubMedCrossRefGoogle Scholar
  22. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98–106PubMedCrossRefGoogle Scholar
  23. Bostwick DG, Brawer MK (1987) Prostatic intraepithelial neoplasia and early invasion in prostatic cancer. Cancer 59: 788–794PubMedCrossRefGoogle Scholar
  24. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP (1992) The association of benign prostatic hyperplasia and cancer of prostate. Cancer 70: 291–301PubMedCrossRefGoogle Scholar
  25. Bostwick DG (1995) High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 75: 1823–1836CrossRefGoogle Scholar
  26. Bostwick DG, Amin MB, Dunndore P, Marsh W, Schultz DS (1993) Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 24: 298–301PubMedCrossRefGoogle Scholar
  27. Bostwick DG, Srigley J, Grignon D et al. (1993) Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 24: 819–832PubMedCrossRefGoogle Scholar
  28. Botticelli AR, Criscuolo M, Martinelli AM (1991) Prostatic value of AgNOR in prostatic carcinomas. Pathol Res Pract 187: 661Google Scholar
  29. Brawer MK (1992) Prostatic intraepithelial neoplasia: a premalignant lesion. Hum Pathol 23: 242–248PubMedCrossRefGoogle Scholar
  30. Brawer MK, Pechl DM, Stamey TA, Bostwick DG (1985) Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45: 3663–3667PubMedGoogle Scholar
  31. Brawer MK, Rennels MA, Nagle RB, Soiderer MH, Lee F (1989a) Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound. J Urol 142: 1510–1512PubMedGoogle Scholar
  32. Brawer MK, Nagle RB. Pitts W, Freiha F. Gamble SL (1989b) Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates. Cancer 63: 454–460PubMedCrossRefGoogle Scholar
  33. Brawn PN (1982) Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 49: 826–833PubMedCrossRefGoogle Scholar
  34. Brawn PN (1992) Histologic features of metastatic prostate cancer. Hum Pathol 23: 267–272PubMedCrossRefGoogle Scholar
  35. Brawn PN, Speights VO (1989) The dedifferentiation of metastatic prostate carcinoma. Br J Cancer 59: 85–88PubMedCrossRefGoogle Scholar
  36. Brawn PN, Speights VO, Contin JU, Bayardo RJ, Kuhl DL (1989) Atypical hyperplasia in prostates of 20–40-year-old men. J Clin Pathol 42: 383–386PubMedCrossRefGoogle Scholar
  37. Brawn PN, Kuhl D, Johnson C, Pandya P, McCord R (1990) Stage D1 prostate carcinoma. The histologic appearance of nodal metastases and its relationship to survival. Cancer 65: 538–543PubMedCrossRefGoogle Scholar
  38. Carter BS, Epstein JI, Isaacs WB (1990) Ras gene mutations in human prostate cancer. Cancer Res 50: 6830–6832PubMedGoogle Scholar
  39. Casiraghi O, Martinez-Madrigal F, Mostofi FK, Micheau C, Caülou B, Tursz T (1991) Primary prostatic Wilms’ tumor. Am J Sure Pathol 15: 885–890CrossRefGoogle Scholar
  40. Chen KTK, Schiff JJ (1983) Adenomatoid prostatic tumor. Urology 21: 88–89PubMedCrossRefGoogle Scholar
  41. Christensen WN, Partin AW, Walsh PC, Epstein JI (1990) Pathologic findings in clinical stage A2 prostate cancer. Cancer 65: 1021–1027PubMedCrossRefGoogle Scholar
  42. Christensen WN, Steinberg G, Walsh PC, Epstein JI (1991) Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 67: 2118–2124PubMedCrossRefGoogle Scholar
  43. Cohen RJ, Glezerson G, Haffejee Z, Afrika D (1990) Prostatic carcinoma. Histological and immunohistological factors affecting prognosis. Br J Urol 66: 405–410PubMedCrossRefGoogle Scholar
  44. Cohen RJ, Glezerson G, Haffejee Z (1991) Neuroendocrine cells — a new prognostic parameter in prostatic cancer. Br J Urol 68: 258–262PubMedCrossRefGoogle Scholar
  45. Coillna G, Botticelli AR, Martinelli AM, Fano PA, Trentini GP (1992) Sclerosing adenosis of the prostate. Report of three cases with electronmicroscopy and immunohisto-chemical study. Histopathology 20: 505–510CrossRefGoogle Scholar
  46. Contractor H, Rüschoff J, Hanisch T, Úlshöfer B, Neumann K, Schultze-Seemann W, Thomas C (1991) Silver-stained structures in prostatic carcinoma: evaluation of diagnostic and prognostic relevance by automated image analysis. Urol Int 46: 9–14PubMedCrossRefGoogle Scholar
  47. Davis BE, Weigel JW (1990) Adenocarcinoma of the prostate discovered in 2 young patients following total prostato vesiculectomy for refractory prostatitis. J Urol 144: 744–745PubMedGoogle Scholar
  48. Dawson NA, Wilding G, Weiss RB et al. (1992) A pilot trial of chemohormonal therapy for metastatic prostate carcinoma. Cancer 69: 213–218PubMedCrossRefGoogle Scholar
  49. Denholm SW, Webb JN, Howard CCW, Chisholm GD (1992) Basaloid carcinoma of the prostate gland: histogenesis and review of the literature. Histopathol 20: 151–155CrossRefGoogle Scholar
  50. Deschenes J, Weidner N (1990) Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease. Am J Surg Pathol 14: 1148–1155PubMedCrossRefGoogle Scholar
  51. Deusel A, Kaduk B, May P (1991) Fall einer äußerst seltenen Organmetastasierung eines Prostatakarzinoms. Urologe B 31: 224–225Google Scholar
  52. Devaney DM, Dorman A, Leader M (1991) Adenoquamous carcinoma of the prostate. A case report. Hum Pathol 22: 1046–1050PubMedCrossRefGoogle Scholar
  53. Dhom G (1990) Unusual prostatic carcinomas. Pathol Res Pract 186: 2836CrossRefGoogle Scholar
  54. Dhom G (1991) Prostata. In: Doerr W, Seifert G (Hrsg) Pathologie des männlichen Genitale. Spezielle pathologische Anatomie, Bd 21. Springer, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S 455–642Google Scholar
  55. Dhom G, Degro S (1982) Therapy of prostatic cancer and histopathologic follow-up. The Prostate 3: 531–542PubMedCrossRefGoogle Scholar
  56. Dundas GS, Porter AT, Venner PM (1990) Prostate specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker. Cancer 66: 45–48PubMedCrossRefGoogle Scholar
  57. Dupont A, Cusan L, Gomez JL, Thibeault MM, Tremblay M, Labrie F (1991) Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate. J Urol 146: 1064–1068PubMedGoogle Scholar
  58. Epstein JI (1990) Evaluation of radical prostatectomy capsular margins of resection — the significance of margins designated as negative, closely approaching, and positive. Am J Surg Pathol 14: 626–632PubMedCrossRefGoogle Scholar
  59. Epstein JI, Steinberg GD (1991) The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume and stage of the biopsied and multifocal tumor. Cancer 66: 1927–1932CrossRefGoogle Scholar
  60. Epstein JI, Cho KR, Quinn BD (1990) Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 65: 2321–2327PubMedCrossRefGoogle Scholar
  61. Epstein JI (1994) Adenosis vs atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 18: 1070–1071PubMedCrossRefGoogle Scholar
  62. Falkmer UG (1992) Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma. Hum Pathol 23: 360–367PubMedCrossRefGoogle Scholar
  63. Falkmer S. Askensten U, Grimelius L, Abrahamsson PA (1990) Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression. Acta Histochem (Jena) [Suppl] 38: 127–132Google Scholar
  64. Faul P, Partecke G (1989) Klinische Bedeutung und Problemstellung des inzidentellen Prostatakarzinoms. Aktuel Urol 20: 1–8CrossRefGoogle Scholar
  65. Fetissof F, Bruandet P, Arbeille B et al. (1986) Calcitonin-secreting carcinomas of the prostate. An immunohisto-chemical and ultrastructural analysis. Am J Surg Pathol 10: 702–710PubMedCrossRefGoogle Scholar
  66. Forsslund G, Esposti PL, Nilsson B, Zetterberg A (1992) The prognostic significance of nuclear DNA content in prostatic carcinoma. Cancer 69: 1432–1439PubMedCrossRefGoogle Scholar
  67. Funa K. Nordgren H. Nilsson S (1991) In situ expression of mRNA for protooncogenes in benign prostatic hyperplasia and in prostatic carcinoma. Scand J Urol Nephrol 25: 95–100PubMedCrossRefGoogle Scholar
  68. Gaffney EF, O’Sullivan SN, O’Brien A (1992) A major solid undifferentiated carcinoma pattern correlates with tumour progression in locally advanced prostatic carcinoma. Histopathology 21: 249–255PubMedCrossRefGoogle Scholar
  69. Gallee MPW, Visser-De Jong E, Ten Kate FJW, Schroeder FH, Kwast TH van der (1989) Monoclonal antibody Ki 67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. J Urol 142: 1342–1346PubMedGoogle Scholar
  70. Gallee MPW, Ten Kate FJW, Mulder PGH, Blom JHM. Heul RO van der (1990) Histological grading of prostatic carcinoma in prostatectomy specimens. Comparison of prognostic accuracy of five grading systems. Br J Urol 65: 368–375PubMedCrossRefGoogle Scholar
  71. Gaudin PB, Epstein JI (1994) Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18: 863–870Google Scholar
  72. Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother 50: 125–130Google Scholar
  73. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23: 273–279PubMedCrossRefGoogle Scholar
  74. Green LK, Klima M (1991) The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast. Hum Pathol 22: 242–246PubMedCrossRefGoogle Scholar
  75. Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR (1988) Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland. An immunohistochemical study. Hum Pathol 19: 1425–1433PubMedCrossRefGoogle Scholar
  76. Haapiainen RK, Permi EJ, Rannikko SAS, Voutilainen PEJ, Liewendahl K, Stenman UH, Alfthan OS (1990) Prostate tumour markers as an aid in the staging of prostatic cancer. Br J Urol 65: 264–267PubMedCrossRefGoogle Scholar
  77. Habib FK, Bissas A, Neill WA, Busuttil A, Chisholm GD (1989) Flow cyometrie analysis of cellular DNA in human prostate cancer: relationship to 5-Alpha-reductase activity of the tissue. Urol Res 17: 239–243PubMedCrossRefGoogle Scholar
  78. Hagood PG, Johnson FE, Bedrossian CWM, Silverberg AB (1991) Small cell carcinoma of the prostate. Cancer 67: 1046–1050PubMedCrossRefGoogle Scholar
  79. Hansen AB, Ostergard B (1990) Nucleolar organizer regions in hyperplastic and neoplastic prostatic tissue. Virchows Archiv [A] 417: 9–13CrossRefGoogle Scholar
  80. Hardeman SW, Soloway MS (1988) Transitional cell carcinoma of the prostate: diagnosis, staging and management. World J Urol 6: 170–174CrossRefGoogle Scholar
  81. Harrison SH, Seale-Hawkins C, Schum CW, Dunn JK, Scardino PT (1992) Correlation between side of palpable tumor and side of pelvic lymph node metastasis in clinically localized prostate cancer. Cancer 69: 750–754PubMedCrossRefGoogle Scholar
  82. Hedrick L, Epstein JI (1989) Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 13: 389–396PubMedCrossRefGoogle Scholar
  83. Helpap B (1981) Cell kinetic and cytological grading of prostatic carcinoma. Virchows Arch [A] 393: 205–214CrossRefGoogle Scholar
  84. Helpap B (1988) Frequency and localization of nucleoli in nuclei from prostatic carcinoma and atypical hyperplasia. Histopathology 12: 203–211CrossRefGoogle Scholar
  85. Helpap B (1989) Pathologie der ableitenden Harnwege und der Prostata. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  86. Helpap B (1991a) Atypical hyperplasia, intraepithelial neoplasia and incidental carcinoma of the prostate. In: Altwein JE, Faul P, Schneider W (eds) Incidental carcinoma of the prostate. Springer, Berlin Heidelberg New York Tokyo, S 74–91CrossRefGoogle Scholar
  87. Helpap B (1991b) Morphologie des Prostatakarzinoms; Histopathologic In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 11–42Google Scholar
  88. Helpap B (1992a) Grading and prognostic significance of urologic carcinomas. Urol Int 48: 245–257PubMedCrossRefGoogle Scholar
  89. Helpap B (1992b) Pathologie der chronischen unspezifischen Prostatitis. In: Vahlensieck W, Rutishauser G (Hrsg) Benigne Prostatopathien. Thieme, Stuttgart New York, 35–50Google Scholar
  90. Helpap B (1993) Atlas der Pathologie urologischer Tumoren. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  91. Helpap B, Koch V (1991) Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy. J Cancer Res Clin Oncol 117: 608–614PubMedCrossRefGoogle Scholar
  92. Helpap B, Bostwick DG, Montironi R (1995) The significance of atypical adenomatous hyperplasia (AHH) and prostatic intraepithelial neoplasia (PIN) for the development of prostate carcinoma. An update. Virchows Arch 426: 425–434Google Scholar
  93. Helpap B, Böcking A, Dhom G, Kastendieck R, Leistenschneider W, Müller HA (1985) Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des Prostatakarzinoms. Eine Empfehlung des pathologisch-urologischen Arbeitskreises „Prostatakarzinom“ Pathologe 6: 3–7Google Scholar
  94. Helpap B, Bubendorf L, Oehler U, Sauter G (1997) Chromogranin A-positive Tumoren in der Prostata. Verh Dtsch Ges Pathol 81: 170Google Scholar
  95. Helpap B, Oehler U, Köllermann J (1996) Erfahrungen aus dem Konsiliardienst für Prostataerkrankungen. Pathologe 17: 417–424PubMedCrossRefGoogle Scholar
  96. Helpap B, Oehler U, Bollmann R (1990) Das endokrin differenzierte Prostatakarzinom. Histologie und Immunhistochemie. Pathologe 11: 18–24PubMedGoogle Scholar
  97. Hermanek P, Sobin LH (1987/1992) TNM classification of malignant tumours. Springer, Berlin Heidelberg New York Tokyo (4th rev. edn. 1987/4th edn., 2nd rev. 1992)CrossRefGoogle Scholar
  98. Hesse A, Neumann K, Thomas C (1990) Immunreaktivität von Prostata- und Harnblasenkarzinomen. Tumor Diagnostik & Therapie 11: 29–32Google Scholar
  99. Honig SC, Stilmant MM, Klavans MS, Freedlund MC, Siroky MB (1992) The role of fine-needle aspiration biopsy of the prostate in staging adenocarcinoma. Cancer 69: 2978–2982PubMedCrossRefGoogle Scholar
  100. Huland H (1991) Morphologische Grundlagen zur radikalen Prostatektomie. Urologe [A] 30: 361–369PubMedGoogle Scholar
  101. Hulman G (1989) “Pseudoadenomatoid” tumour of prostate. Histopathology 14: 317–323PubMedCrossRefGoogle Scholar
  102. Hulse CA, O’Neill T (1989) Adenocarcinoma of the prostate metastatic to the ureter with an associated ureteral stone. J Urol 142: 1312–1313PubMedGoogle Scholar
  103. Humphrey PA, Walther PJ, Currin SM, Vollmer RT (1991) Histologic grade, DNA ploidy and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 15: 1165–1170PubMedCrossRefGoogle Scholar
  104. Idikio HA, Manickavel V (1991) Correlation of blood group antigen expression and oncogene-related proteins in malignant prostatic tissues. Pathol Res Pract 187: 189–197PubMedCrossRefGoogle Scholar
  105. Jones EC, McNeal J, Bruchovsky N, Jong G de (1990) DNA content in prostatic adenocarcinoma. Cancer 66: 752–757PubMedCrossRefGoogle Scholar
  106. Jones EC, Clement PB, Young RH (1991) Sclerosing adenosis of the prostate gland. Am J Surg Pathol 15: 1171–1180PubMedCrossRefGoogle Scholar
  107. Jones H, Anthony PP (1992) Metastatic prostatic carcinoma presenting as left-sided cervical lymphadenopathy: a series of 11 cases. Histopathology 21: 149–154PubMedCrossRefGoogle Scholar
  108. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cytoprostatectomy for other causes. Incidence, histology and morphometric observations. J Urol 141: 1091–1094PubMedGoogle Scholar
  109. Kaplan ID, Prestidge BR, Cox RS, Bagshaw MA (1990) Prostate specific antigen after irradiation for prostatic carcinoma. J Urol 144: 1172–1176PubMedGoogle Scholar
  110. Kaplan ID, Cox RS, Bagshaw MA (1991) A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy. Cancer 68: 400–405PubMedCrossRefGoogle Scholar
  111. Kastendieck R (1993) Die Pathologie des Prostatakarzinoms: Neue Wege zum Verständnis seiner Entwicklung und biologischen Wertigkeit. Verh Dtsch Pathol 77: 40–69Google Scholar
  112. Kastendieck H, Helpap B (1989) Prostatic dysplasia/atypical hyperplasia. Terminology, pathobiology, and significance. Urology (Suppl) 34: 28 – 42PubMedCrossRefGoogle Scholar
  113. Kelemen PR, Buschmann RJ, Weisz-Carrington P (1990) Nucleolar prominence as a diagnostic variable in prostcancic carcinoma. Cancer 65: 1017–1020PubMedCrossRefGoogle Scholar
  114. Kernion de JB, Neuwirth H, Stein A, Dorey F, Stenzl A, Hannah J, Blyth B (1990) Prognosis of patients with stage D1 prostate carcinoma following radical prostatec tomy with and without early endocrine therapy. J Urol 144: 700–703Google Scholar
  115. Klein EA (1990) Die Genetik urologischer Tumoren. Teil 1. Zytogenetische und molekularbiologische Grundlagen. Aktuel Urol 21: 303–311CrossRefGoogle Scholar
  116. Klein EA (1991) Die Genetik urologischer Tumoren. Teil 2. Klassische und zytogenetische Konzepte der Karzinomgenese und chromosomale Aberrationen bei speziellen urologischen Tumoren. Aktuel Urol 22: 1–9CrossRefGoogle Scholar
  117. Klöppel G (Hrsg) Aktuelle Pathologie der Prostata und der ableitenden Harnwege. Verh Dtsch Ges Pathol 77. Tagung Würzburg. Fischer, Stuttgart Jena New YorkGoogle Scholar
  118. Konishi N, Enomoto T, Buzard G, Ohshima M, Ward IM, Rice JM (1992) K-ras activation and ras p2i expression in latent prostatic carcinoma in Japanese men. Cancer 69: 2293–2299PubMedCrossRefGoogle Scholar
  119. Kuban DA, El-Mahdi AM, Schellhammer PF (1989a) Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma. Cancer 63: 2421–2425PubMedCrossRefGoogle Scholar
  120. Kuban DA, El-Mahdi AM, Schellhammer PF (1989b) 1–125 interstitial implantation for prostate cancer. What have we learned 10 years later? Cancer 63: 2415–2420PubMedCrossRefGoogle Scholar
  121. Larsen MP, Carter HB, Epstein JI (1991) Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease. J Urol 146: 1059–1063PubMedGoogle Scholar
  122. Lee F, Siders DB, Torp-Pedersen ST, Kirscht JL, Mc Hugh TA, Mitchell AE (1991) Prostate cancer. Transrectal ultrasound and pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer. Cancer 67: 1132–1142PubMedCrossRefGoogle Scholar
  123. Lerner SP, Seale-Hawkins C, Carlton CE, Scardino PT (1991) The risk of dying of prostate cancer in patients with clinically localized disease. J Urol 146: 1040–1045PubMedGoogle Scholar
  124. Löbelenz M, Pfiester P, Potempa D, Rassweiler J, Alken P (1989) Malignes Schwannom der Prostata. Aktuel Urol 20: 345–347CrossRefGoogle Scholar
  125. Loughlin KR, Retik AB, Weinstein HJ, Colodny AH, Shamberger RC, Delorey M, Tarbell N (1989) Genitourinary rhabdomyosarcoma in children. Cancer 63: 1600–1606PubMedCrossRefGoogle Scholar
  126. McNeal JE (1988a) Normal histology of the prostate. Am J Surg Pathol 12: 619–633PubMedCrossRefGoogle Scholar
  127. McNeal JE (1988b) Significance of duct-acinar dysplasia in prostatic carcinogenesis. The Prostate 13: 91–102PubMedCrossRefGoogle Scholar
  128. McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread. Hum Pathol 23: 258–266PubMedCrossRefGoogle Scholar
  129. McNeal JE, Bostwick DG (1986) Intraductal dysplasia. A premalignant lesion of the prostate. Hum Pathol 17: 64– 71PubMedCrossRefGoogle Scholar
  130. McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12/12: 897–906CrossRefGoogle Scholar
  131. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA (1991)) Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66: 1225–1233CrossRefGoogle Scholar
  132. McNeal JE, Alroy J, Villers A, Redwine EA, Freiha FS, Stamey TA (1991a) Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol 22: 979–988PubMedCrossRefGoogle Scholar
  133. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA (1991b) Microcarcinoma in the prostate. Its association with duct-acinar dysplasia. Hum Pathol 22: 644–652PubMedCrossRefGoogle Scholar
  134. Meister P, Heidi G (1991) Postoperativer Spindelzellknoten der Harnblase und Prostata. Pathologe 12: 214–219PubMedGoogle Scholar
  135. Mohler JL, Partin AW, Epstein JI et al. (1992) Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer 69: 511–519PubMedCrossRefGoogle Scholar
  136. Moldwin RM, Orihuela E (1989) Breast masses associated with adenocarcinoma of the prostate. Cancer 63: 2229–2233PubMedCrossRefGoogle Scholar
  137. Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke R, Therneau TM (1990) Stage B prostate adenocarcinoma - flow cytometric nuclear DNA ploidy analyses. Arch Surg 125: 327–331PubMedCrossRefGoogle Scholar
  138. Montie JE, Wood DP, Pontes JE, Boyett JM, Levin HS (1989) Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63: 381– 385PubMedCrossRefGoogle Scholar
  139. Montironi R, Scarpelli M, Maggi Galluzzi C, Diamanti L (1992) Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN). J Cell Biochem Suppl 16H: 47–53PubMedCrossRefGoogle Scholar
  140. Montironi R, Scarpelli M, Sisti S, Braccischi A, Mariuzzi GM (1990a) Morphological and quantitative analyses of intraductal dysplasia of the prostate. Anal Cell Pathol 2: 277–285PubMedGoogle Scholar
  141. Montironi R. Scarpelli M, Sisti S, Braccischi A, Gusella P, Alberti R, Mariuzzi GM (1990b) Cytometric evaluation of the intraepithelial neoplasia of the prostate gland. Ann NY Acad Sci 595: 403–405CrossRefGoogle Scholar
  142. Montironi R, Braccischi A, Matera G, Scarpelli M, Pisani E (1991) Quantitation of the prostatic intraepithelial neoplasia. Analysis of the nucleolar size, number and location. Pathol Res Pract 187: 307–314PubMedCrossRefGoogle Scholar
  143. Mostofì FK, Sesterhenn IA, Sobin LH (1980) Histological typing of prostate tumours. International histological classification of tumours. No 22. World Health Organisation, GenevaGoogle Scholar
  144. Mostofì FK, Sesterhenn IA, Davies CJ (1992a) Prostatic carcinoma: Problems in the interpretation of prostatic biopsies. Hum Pathol 23: 223–241PubMedCrossRefGoogle Scholar
  145. Mostofì FK, Davies CJ, Sesterhenn IA (1992b) Pathology of carcinoma of the prostate. Cancer [suppl] 70: 235–253PubMedCrossRefGoogle Scholar
  146. Moul JW, Paulson DF, Fuller G, Gottfried MR, Floyd WL (1989) Prostate cancer with solitary parotid metastasis correctly diagnosed with immunohistochemical stains. J Urol 142: 1328–1329PubMedGoogle Scholar
  147. Müller HA, Altenähr E, Böcking A et al. (1980) Über Klassifikation und Grading des Prostatakarzinoms. Verh Dtsch Ges Pathol 64: 609611Google Scholar
  148. Mulders PFA, Dijkman GA, del Moral PF, Theeuwes AGM, Debruyne FMJ et al. (1990) Analysis of prognostic factors in disseminated prostatic cancer. An update. Cancer 65: 2758–276PubMedCrossRefGoogle Scholar
  149. Murphy WM (1989) Urological pathology. Saunders, Philadelphia San Diego London Toronto Montreal Sydney TokyoGoogle Scholar
  150. Nagle RB, Brawer MK, Kittelson J, Clark V (1991) Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 138: 119–128PubMedGoogle Scholar
  151. Nagle RB, Petein M, Brawer M, Bowden GT, Cress AG (1992) New relationships between prostatic intraepithelial neoplasia and prostatic carcinoma. J Cell Biochem Suppl 16H: 26–29PubMedCrossRefGoogle Scholar
  152. Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM (1990) Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J Urol 144: 303–306PubMedGoogle Scholar
  153. Nazeer T, Barada JH, Fischer HAG, Ross JS (1991) Prostatic carcinosarcoma: case report and review of literature. J Urol 146:1370–1373PubMedGoogle Scholar
  154. Nelson RS, Epstein JI (1996) Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma. Am J Surg Pathol 20: 419–426PubMedCrossRefGoogle Scholar
  155. Nemoto R, Hattori K, Uchida K, Shimazui T, Nishijima Y, Koiso K, Harada M (1990) S-phase fraction of human prostate adenocarcinoma studied with in vivo bromode-oxyuridine labeling. Cancer 66: 509–514PubMedCrossRefGoogle Scholar
  156. Nusko G, Löhr M, Hahn EG (1992) Genetische Veränderungen in der Pathogenese maligner Erkrankungen. Klinikarzt 21: 76–81Google Scholar
  157. Okada H, Tsubura A, Okamura A, Senzaki H, Naka J, Komatz J, Morü S (1992) Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch [A] 421: 157–161CrossRefGoogle Scholar
  158. O’Malley FP, Grignon DJ, Shum DT (1990) Usefullness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Archiv [A] 417: 191–196CrossRefGoogle Scholar
  159. Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI (1992) Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer 70: 161–168PubMedCrossRefGoogle Scholar
  160. Perlman EJ, Epstein JI (1990) Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol 14: 810–818PubMedCrossRefGoogle Scholar
  161. Perrapato SD, Shah PC, Huben RP, Gaeta JF (1991) Locally recurrent endometrioid adenocarcinoma of the prostate after radical prostatectomy. J Urol 145: 373–375PubMedGoogle Scholar
  162. Petersen RO (1986) Urologic pathology. Lippincott, Philadelphia London Mexico City New York St. Louis San Paulo SydneyGoogle Scholar
  163. Pinder SE, McMahon RFT (1990) Mucins in prostatic carcinoma. Histopathology 16: 43–46PubMedCrossRefGoogle Scholar
  164. Pienkos El, Meisner LF (1991) Adenocarcinoma of the prostate in A 41-year-old man with xxy karyotype and chronic lymphocytic leukemia. Report of a case. J Urol 145: 148–150Google Scholar
  165. Quinn BD, Cho KR, Epstein JI (1990) Relationship of servere dysplasia to stage B adenocarcinoma of the prostate. Cancer 65: 2328–2337PubMedCrossRefGoogle Scholar
  166. Rackley RR, Yang B, Pretlow TG et al. (1991) Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia. Cancer 68: 587–593PubMedCrossRefGoogle Scholar
  167. Ro JY, El-Naggar A, Ayala AG, Mody DR, Ordonez NG (1988) Signet-ring-cell carcinoma of the prostate. Electronmicroscopic and immunohistochemical studies of eight cases. Am J Surg Pathol 12: 453–460PubMedCrossRefGoogle Scholar
  168. Ro JY, Grignon DJ, Ayala AG, Fernandez PL, Ordonez NG, Wishnow KI (1990) Mucinous adenocarcinoma of the prostate. Histochemical and immunohistochemical studies. Hum Pathol 21: 593–600PubMedCrossRefGoogle Scholar
  169. Rojas-Corona RR, Chen L, Mahadevia PS (1987) Prostatic carcinoma with endocrine features. A report of a neoplasm containing multiple immunoreactive hormonal substances. Am J Clin Pathol 88: 759–762PubMedGoogle Scholar
  170. Ronnett BM, Epstein JI (1989) A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate. Am J Surg Pathol 13: 866–872PubMedCrossRefGoogle Scholar
  171. Ruizeveld de Winter JA, Trapman J et al. (1990) Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol 161: 329–332Google Scholar
  172. Russell KJ, Dunatov C, Hafermann MD et al. (1991) Prostate specific antigen in the management of patients with localized adenocarcinoma of the protate treated with primary radiation therapy. J Urol 146: 1046–1052PubMedGoogle Scholar
  173. Sadi MV, Barrack ER (1991) Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy. Cancer 67: 3065–3071PubMedCrossRefGoogle Scholar
  174. Sadi MV, Walsh PC, Barrack ER (1991) Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67: 3057–3064PubMedCrossRefGoogle Scholar
  175. Sant’Agnese PA (1988) Neuroendocrine differentiation and prostatic carcinoma. The concept “comes of age”. Arch Pathol Lab Med 112: 1097–1099PubMedGoogle Scholar
  176. Sant’Agnese PA (1992a) Neuroendocrine differentiation in human prostatic carcinoma. Human Pathol 23: 287–296CrossRefGoogle Scholar
  177. Sant’Agnese PA (1992b) Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer [suppl] 70: 254–268PubMedCrossRefGoogle Scholar
  178. Sar M, Lubahn DB, French FS, Wilson EM (1990) Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127: 3180–3186PubMedCrossRefGoogle Scholar
  179. Sakamoto N, Tsuneyoshi M, Enjoji M (1991) Sklerosing adenosis of the prostate. Histopathologic and immunohistochemical analysis. Am J Surg Pathol 15: 660–667PubMedCrossRefGoogle Scholar
  180. Schellhammer PF (1991) Local failure and related complications after definitive treatment of clinical stage C carcinoma of the prostate by irradiation or surgery. Semin Urol 4: 232–246Google Scholar
  181. Schmid HP, McNeal JE (1992) An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16: 184–191PubMedCrossRefGoogle Scholar
  182. Scrivner DL, Meyer JS, Rujanavech MN, Fathman A, Scully T (1991) Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies. J Urol 146: 1034–1039PubMedGoogle Scholar
  183. Scully MF, Uno JM, Mclntyre M, Mosely S (1990) Radiation-induced prostatic sarcoma. A case report. J Urol 144: 746–748PubMedGoogle Scholar
  184. Sesterhenn IA, Becker RL, Avallone FA, Mostofi FK, Lin TH, Davis jr CJ (1991) Image analysis of nucleoli and nucleolar organizer regions in prostatic hyperplasia, intraepithelial neoplasia and prostatic carcinoma. Urogenit Pathol 1: 61–75Google Scholar
  185. Shinohara K, Wheeler TM, Scardino PT (1989) The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 142: 76–82PubMedGoogle Scholar
  186. Sobin LH, Wittekind Ch (1997) Classification of malignant tumours. 5th ed Wiley-Liss, New York Chichester Weinheim Brisbane Singapore Toronto, pp 170–173Google Scholar
  187. Srigley JR, Dardick I, Warren R, Hartwick J, Klotz L (1990) Basal epithelial cells of human prostate gland are not myoepithelial cells: a comparative immunohistochemical and ultrastructural study with the human salivary gland. Am J Pathol 136: 957–966PubMedGoogle Scholar
  188. Stamey TA (1990) Die Rolle des prostataspezifischen Antigens bei der Diagnose und Behandlung des Prostataadenokarzinoms. Urologe A 29: 52–64PubMedGoogle Scholar
  189. Stamey TA (1991) Prostatakarzinom - Klinische und mor-phometrische Grundlagen. Urologe A 30: 348–360PubMedGoogle Scholar
  190. Stiens R, Helpap B, Weißbach L (1981) Quantitative Untersuchungen zum Zellverlust in Prostatacarcinomen. Klinisch-morphologische Aspekte. Verh Dtsch Ges Urol 32: 73–74Google Scholar
  191. Suzuki H, Nakada T, Iijima Y, Kaneko H, Suzuki Y, Ishii N, Onmura Y (1991) Malignant lymphoma of the prostate: report of a case. Urol Int 47: 172–175PubMedCrossRefGoogle Scholar
  192. Svanholm H, Starklint H, Barlebo H, Olsen S (1989) Histological evaluation of prostatic cancer. (I) Reproducibility of tumour type. APMIS 97: 699–704PubMedCrossRefGoogle Scholar
  193. Svanholm H, Starklint H, Barlebo H, Olsen S (1990a) Histological evaluation of prostatic cancer (II): Reproducibility of a histological grading system. APMIS 98: 229–236PubMedCrossRefGoogle Scholar
  194. Svanholm H, Starklint H, Barlebo H, Olsen S (1990b) Histological evaluation of prostatic cancer (III): Reproducibility of assessment of tumor volume and its possible significance for prognosis. APMIS 98: 237–243PubMedCrossRefGoogle Scholar
  195. Tribukait B (1987) Flow cytometry in assessing the clinical agressiveness of genitourinary neoplasms. World J Urol 5: 108–122CrossRefGoogle Scholar
  196. Voges G, Hohenfellner R (1990) Prostatakarzinom: Keine Behandlung - eine Option bei klinisch lokalisiertem Tumor? Aktuel Urol 21: 232–233CrossRefGoogle Scholar
  197. Voges GE, McNeal JE, Stamey TA (1991) Das inzidentelle Prostatakarzinom: Volumen ,Lokalisation und Differenzierungsgrad des Tumors im radikalen Prostatektomie-präparat und Stellenwert der Subklassifikation in ein Stadium A1 und A2. Urologe [A] 30: 401–409Google Scholar
  198. Voges GE ,McNeal JE ,Redwine EA ,Freiha FS ,Stamey TA (1992) Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 69: 520–526PubMedCrossRefGoogle Scholar
  199. Ware JL ,Maygarden SJ ,Koontz WW ,Strom SC (1991) Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Hum Pathol 22: 254–258PubMedCrossRefGoogle Scholar
  200. Waring PM ,Newland RC (1992) Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic Review. Cancer 69: 755–762PubMedCrossRefGoogle Scholar
  201. Weaver MG ,Ahdul-Karim FW ,Srigley J ,Bostwick DG ,Ro JY ,Ayala AG (1992) Paneth cell-like change of the prostate gland. A histological, immunohistochemical and electron microscopic study. Am J Surg Pathol 16: 62–68PubMedCrossRefGoogle Scholar
  202. Wernert N (1991) Immunhistochemie der Prostata und des Prostatakarzinoms. Fischer ,StuttgartGoogle Scholar
  203. Wernert N ,Lüchtrath H ,Seeliger H ,Schäfer M ,Goebbels R ,Dohm G (1987) Papillary carcinoma of the prostate localisation and immunhistochemistry. The histogenesis and entity of so-called endometrioid carcinoma. Prostate 10: 123–131PubMedCrossRefGoogle Scholar
  204. Wernert N ,Bonkhoff H ,Seitz G ,Remberger K ,Dhom G (1989) Untersuchungen zur Proliferationsaktivität (Ki 67) im normalen ,hyperplastischen und karzinomatösen Prostatagewebe. Verfi Dtsch Ges Pathol 73: 637Google Scholar
  205. Wernert N ,Goebbels R ,Bonkhoff H ,Dhom G (1990) Squamous cell carcinoma of the prostate. Histopathology 17:339–344PubMedCrossRefGoogle Scholar
  206. Willumsen H ,Thorup J ,Norgaard T ,Hart-Hansen O (1988) Nuclear DNA content in prostatic carcinoma measured by flow cytometry. A retrospective study on paraffin embedded tissue. APMIS [Suppl] 4: 120–125Google Scholar
  207. Winkler HZ ,Rainwater LM ,Myers RP ,Farrow GM ,Therneau TM ,Zincke H ,Lieber MM (1988) Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy pattern studied by flow cytometry. Mayo Clin Proc 63: 103–112PubMedGoogle Scholar
  208. Whitmore WF (1990) Locoregional prostatic cancer. Advances in management. Cancer 65: 667–674PubMedCrossRefGoogle Scholar
  209. Wood DP ,Montie JE ,Pontes JE ,Levin HS (1989a) Identification of transitional cell carcinoma of the prostate in bladder cancer patients. A prospective study. J Urol 142: 83–85PubMedGoogle Scholar
  210. Wood DP ,Montie JE ,Pontes JE ,Medendorp SV ,Levin HS (1989b) Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 141:346–349PubMedGoogle Scholar
  211. Yao JCT ,Wang WCC ,Tseng HH ,Hwang WS (1988) Primary rhabdomyosarcoma of the prostate. Diagnosis by needle biopsy and immunocytochemistry. Acta Cytol (Baltimore) 32: 509–512Google Scholar
  212. Young R ,Clement PB (1987) Sclerosing adenosis of the prostate. Arch Pathol Lab Med 111: 363–366PubMedGoogle Scholar
  213. Young RH ,Frierson Jr HF ,Mills SE ,Kaiser JS ,Talboth WH ,Bhan AK (1988/1989) Adenoid cystic-like tumor of the prostate gland: a report of two cases and review of the literature on “adenoid cystic carcinoma” of the prostate. Am J Clin Pathol 88; 89: 49–56Google Scholar
  214. Yum M ,Miller JC, Agrawal BL (1991) Leiomyosarcoma arising in atypical fìbromuscular hyperplasia (phyllodes tumor) of the prostate with distant metastasis. Cancer 68: 910–915PubMedCrossRefGoogle Scholar
  215. Zagars GK, Sherman NE, Babaian RJ (1991) Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer 67: 412–420PubMedCrossRefGoogle Scholar
  216. Zenklusen HR, Weymuth G, Rist M, Mihatsch MJ (1990) Carcinosarcoma of the prostate in combination with adenocarcinoma of the prostate and adenocarcinoma of the seminal vesicles. A case report with immunocyto-chemical analysis and review of the literature. Cancer 66: 998–1001PubMedCrossRefGoogle Scholar
  217. Zincke H, Blute ML, Fallen MJ, Farrow GM (1991) Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. J Urol 146: 1053–1058PubMedGoogle Scholar
  218. Zincke H, Bergstralh EJ, Larson-Keller JJ, Farrow GM, Myers RP, Lieber MM, Barrett DM, Rife CC, Gonchoroff NJ (1992) Stage Di prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer 70: 311–323PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • B. Helpap

There are no affiliations available

Personalised recommendations